EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Examination of In Vivo Mutations in VP4 (VP8*) of the Rotarix® Vaccine from Shedding of Children Living in the Amazon Region

Mauro França Silva, Beatriz Vieira da Silva, Emanuelle Ramalho, Yan Cardoso Pimenta iD, Leonardo Luiz Pimenta da Silva, Laricy da Silva Vieira, Maria da Penha Trindade Pinheiro Xavier, Alberto Ignacio Olivares Olivares, José Paulo Gagliardi Leite iD, Marcia Terezinha Baroni de Moraes

Viruses · 2026

DOI: 10.3390/v18010070 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Viruses, 2026. Verfasst von Mauro França Silva und 9 weiteren Autor:innen. Beteiligte Einrichtung: Program in Tropical Medicine, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Fiocruz, Avenida Brasil, 4365-Manguinhos, Rio de Janeiro 21040-360, Br…. Hauptthemen laut MEDLINE: Rotavirus Vaccines, Rotavirus, Rotavirus Infections, Mutation. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: CNPq, Faperj, Oswaldo Cruz Institute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Group A rotaviruses (RVAs) remain the leading cause of acute gastroenteritis (AGE) in young children in low- and middle-income countries. In Brazil, the oral attenuated RVA vaccine (Rotarix®), monovalent genotype G1P[8], is distributed by the national immunization program and has drastically reduced morbidity and mortality associated with RVA etiology. In this study, Rotarix® G1P[8] was detected using specific qRT-PCR from the fecal shedding of children living in the Amazon region, and 18.3% (29/158) were positive and 75.8% (22/29) presented with AGE. The VP4 (VP8*) gene of these sheddings, submitted to Sanger nucleotide sequencing, showed an occurrence of mutations, including the silent mutation at 144C > G (one child) and the following missense mutations— 499T > C (F167L) (two children), 644G > C (C215S) (one child), and 787G > A (E263K) (one child). These mutations had no impact on the protein model structure in silico deduced from the VP4 (VP8*) mutants. The in silico protein model deduced from the VP4 (VP8*) nucleotide sequences, bound to type 1H sugar antigens (H1) and its precursor Lac-para-N-biose (LNB), had a stronger binding to the G1P[8] genotype, when compared to G3P[8]. Rotarix® shedding was higher in HBGA secretors than in non-secretors (79.3%; 23/29). A total of 11.4% (18/158) of children with Rotarix® G1P[8] shedding were unvaccinated, indicating the occurrence of indirect protection. Stability evidence of Rotarix® VP4 (VP8*) spike protein from samples collected in vivo is presented.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Rotavirus VaccinesRotavirusRotavirus InfectionsMutationViral Nonstructural ProteinsVirus SheddingRNA-Binding ProteinsHumansVaccines, AttenuatedBrazilFecesGastroenteritisInfantChild, PreschoolGenotypeCapsid Proteins

Stichwörter der Autor:innen

Histo Blood Group AntigenRotarix®Rotavirus Aacute gastroenteritis

Substanzen

Vaccines, AttenuatedRIX4414 vaccineRotavirus VaccinesViral Nonstructural ProteinsVP4 protein, RotavirusRNA-Binding ProteinsCapsid ProteinsNS35 protein, rotavirus

Autor:innen und Institutionen

  • Program in Tropical Medicine, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Fiocruz, Avenida Brasil, 4365-Manguinhos, Rio de Janeiro 21040-360, Brazil.
  • Technological Coordination, Tetraviral Vaccine, Immunobiological Technology Institute (Biomanguinhos), Oswaldo Cruz Foundation, Fiocruz, Avenida Brasil, 4365-Manguinhos, Rio de Janeiro 21040-360, Brazil.
  • Laboratory of Comparative and Environmental Virology, Oswaldo Cruz Institute, Oswaldo Cruz Foundation, Fiocruz, Avenida Brasil, 4365-Manguinhos, Rio de Janeiro 21040-360, Brazil.
  • Secretaria Estadual de Saúde de Roraima, SESAU/RR, Rua Madrid, 180-Aeroporto, Boa Vista 69310-043, Brazil.
  • College of Medicine, State University of Roraima, Avenida Helio Campo, s/n-Centro, Caracaraí, Boa Vista 69360-000, Brazil.

ORCID-Profile: Yan Cardoso Pimenta, José Paulo Gagliardi Leite

Förderung

  • CNPq
  • Faperj
  • Oswaldo Cruz Institute
  • National Council for Scientific and Technological Development
  • Foundation for Research Support of the State of Rio de Janeiro
  • José Paulo Gagliardi Leite

Zitieren

APA

Silva, M. F., Silva, B. V. D., Ramalho, E., Pimenta, Y. C., Silva, L. L. P. D., Vieira, L. D. S., Xavier, M. D. P. T. P., Olivares, A. I. O., Leite, J. P. G., & Moraes, M. T. B. (2026). Examination of In Vivo Mutations in VP4 (VP8*) of the Rotarix® Vaccine from Shedding of Children Living in the Amazon Region. Viruses. https://doi.org/10.3390/v18010070

Vancouver

Silva MF, Silva BVD, Ramalho E, Pimenta YC, Silva LLPD, Vieira LDS, et al. Examination of In Vivo Mutations in VP4 (VP8*) of the Rotarix® Vaccine from Shedding of Children Living in the Amazon Region. Viruses. 2026. doi:10.3390/v18010070

BibTeX
@article{Silva2026,
  author = {Silva, Mauro França and Silva, Beatriz Vieira da and Ramalho, Emanuelle and Pimenta, Yan Cardoso and Silva, Leonardo Luiz Pimenta da and Vieira, Laricy da Silva and Xavier, Maria da Penha Trindade Pinheiro and Olivares, Alberto Ignacio Olivares and Leite, José Paulo Gagliardi and Moraes, Marcia Terezinha Baroni de},
  title = {Examination of In Vivo Mutations in VP4 (VP8*) of the Rotarix® Vaccine from Shedding of Children Living in the Amazon Region},
  journal = {Viruses},
  year = {2026},
  doi = {10.3390/v18010070}
}
Kostenlos starten →